Alicia Ruppelt is a scientist specialized in bioprinting, tissue engineering, and ex vivo perfusion. Currently serving as the Liver Program Leader at Cellbricks, Alicia is passionate about biomedical research and 3D bioprinting. Alicia has completed a Master of Science and a Bachelor of Science in Biotechnology from Technische Universität Berlin, and has accumulated diverse experience through roles at notable organizations, including Merck KGaA and LifeTec Group™. Additionally, Alicia has contributed to research as a PhD candidate and Marie Skłodowska-Curie Fellow at Politecnico di Milano.
This person is not in the org chart
This person is not in any teams
This person is not in any offices